-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
9 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$2.11 M
Travere Therapeutics, Inc. Insider Transactions
Travere Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 2,174 @ $8.53 | $18,547 | 58,074 | 02/01/2024 | 02/02/2024 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 3,818 @ $8.53 | $32,573 | 70,903 | 02/01/2024 | 02/02/2024 | |
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY |
Sell | 2,062 @ $8.96 | $18,476 | 56,034 | 01/23/2024 | 01/25/2024 | |
|
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER |
Sell | 7,873 @ $8.96 | $70,542 | 234,722 | 01/23/2024 | 01/25/2024 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 853 @ $9.07 | $7,735 | 49,721 | 01/23/2024 | 01/25/2024 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 2,062 @ $8.96 | $18,476 | 60,484 | 01/23/2024 | 01/25/2024 | |
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 910 @ $9.07 | $8,252 | 41,337 | 01/23/2024 | 01/25/2024 | |
|
Heerma Peter
CHIEF COMMERCIAL OFFICER |
Sell | 1,559 @ $9.07 | $14,138 | 78,698 | 01/23/2024 | 01/25/2024 | |
|
Inrig Jula
Chief Medical Officer |
Sell | 440 @ $9.17 | $4,035 | 35,248 | 01/04/2024 | 01/05/2024 | |
|
Inrig Jula
Chief Medical Officer |
Sell | 2,069 @ $9.48 | $19,613 | 35,688 | 01/03/2024 | 01/05/2024 | |
|
Heerma Peter
Chief Commercial Officer |
Sell | 3,091 @ $8.25 | $25,504 | 80,257 | 10/03/2023 | 10/04/2023 | |
| Sell | 457 @ $14.71 | $6,723 | 50,574 | 09/05/2023 | 09/05/2023 | ||
|
ROTE WILLIAM E.
Senior Vice President, R&D |
Sell | 1,815 @ $14.71 | $26,699 | 61,173 | 09/05/2023 | 09/05/2023 | |
|
REED ELIZABETH E
SVP, GC & Corporate Secretary |
Sell | 1,815 @ $14.71 | $26,699 | 58,096 | 09/05/2023 | 09/05/2023 | |
|
Dube Eric M
CEO |
Sell | 4,455 @ $14.71 | $65,533 | 242,595 | 09/05/2023 | 09/05/2023 | |
|
Calvin Sandra
SVP, CAO |
Sell | 122 @ $16.12 | $1,967 | 42,247 | 05/11/2023 | 05/12/2023 | |
| Sell | 455 @ $16.59 | $7,548 | 51,031 | 05/10/2023 | 05/12/2023 | ||
|
REED ELIZABETH E
SVP, GC & Corporate Secretary |
Sell | 825 @ $16.59 | $13,687 | 56,611 | 05/10/2023 | 05/12/2023 | |
|
ROTE WILLIAM E.
Senior Vice President, R&D |
Sell | 825 @ $16.59 | $13,687 | 59,211 | 05/10/2023 | 05/12/2023 | |
|
Calvin Sandra
SVP, CAO |
Sell | 436 @ $16.59 | $7,233 | 42,369 | 05/10/2023 | 05/12/2023 |
Travere Therapeutics, Inc. Frequently Asked Questions
-
Who is on Travere Therapeutics, Inc.'s Insider Roster?
The list of insiders at Travere Therapeutics, Inc. includes Inrig Jula, Heerma Peter, Calvin Sandra, ROTE WILLIAM E., Cline Christopher R., Dube Eric M, REED ELIZABETH E, Meckler Jeffrey A, LYONS GARY A.
-
How much insider selling is happening at Travere Therapeutics, Inc.?
Insiders have sold a total of 177,508 Travere Therapeutics, Inc. shares in the last 12 months for a total of 2.11 M sold.
-
Which Travere Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Travere Therapeutics, Inc. shares in the last 12 months: Inrig Jula ($76,313), Heerma Peter ($75,167), Calvin Sandra ($32,310), ROTE WILLIAM E. ($110,509), Cline Christopher R. ($74,244), Dube Eric M ($480,337), REED ELIZABETH E ($110,509), Meckler Jeffrey A ($562,324), LYONS GARY A ($589,101),